Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
28 hedge funds and large institutions have $24.2M invested in Alpine Immune Sciences Inc in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 13 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
9% more capital invested
Capital invested by funds: $22.3M → $24.2M (+$1.93M)
26% less funds holding
Funds holding: 38 → 28 (-10)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$533K |
| 2 |
SIM
Spark Investment Management
New York
|
+$364K |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$281K |
| 4 |
BlackRock
New York
|
+$231K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.85M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$1.17M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$422K |
| 4 |
PA
Perceptive Advisors
New York
|
-$274K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$250K |
ALPN Hedge Fund Activity: Q1 2017 in Review
28 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2017, worth a combined $24.2M — up 8.7% from $22.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ALPN and 9 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $533K. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.85M sold.
- 28 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2017, down from 38 in Q4 2016.
- Funds reported $24.2M of Alpine Immune Sciences Inc stock for Q1 2017, up 8.7% quarter-over-quarter.
- 9 funds opened new Alpine Immune Sciences Inc positions in Q1 2017 and 13 closed out, a net change of -4 holders.
- The largest Alpine Immune Sciences Inc buyer in Q1 2017 was Vanguard Group, an estimated $533K added.
- The largest Alpine Immune Sciences Inc seller in Q1 2017 was Wellington Management Group, an estimated $2.85M sold.
Based on aggregated 13F filings for Q1 2017.